French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases-Reference-Cited by-同舟云学术

French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases

Published:2024-02 Issue:2 Volume:45 Page:79-99
ISSN:0248-8663
Container-title:La Revue de Médecine Interne
language:en
Short-container-title:La Revue de Médecine Interne

Author:

Farge D.^ORCID,Pugnet G.,Allez M.,Castilla-Llorente C.,Chatelus E.,Cintas P.,Faucher-Barbey C.,Labauge P.,Labeyrie C.,Lioure B.^ORCID,Maria A.^ORCID,Michonneau D.^ORCID,Puyade M.^ORCID,Talouarn M.,Terriou L.^ORCID,Treton X.,Wojtasik G.,Zephir H.^ORCID,Marjanovic Z.

Publisher

Elsevier BV

Reference103 articles.

1. Treatment of severe autoimmune disease by stem-cell transplantation;Sykes;Nature,2005

2. Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT);Tyndall;Bone Marrow Transplant,1997

3. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation;Snowden;Bone Marrow Transplant,2012

4. [Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC];Farge;Pathol Biol,2014

5. Update of EULAR recommendations for the treatment of systemic sclerosis;Kowal-Bielecka;Ann Rheum Dis,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prérequis et organisation du parcours de soins en vue de l’utilisation d’une thérapie cellulaire ou génique par cellules stromales mésenchymateuses (CSM) ou par cellules T porteuses d’un récepteur antigénique chimérique (CAR-T cells) chez les patients avec maladies auto-immunes systémiques;Bulletin du Cancer;2024-09

2. Systemic sclerosis, silica exposure and cellular therapies: The sand in the gears?;La Revue de Médecine Interne;2024-07